| East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More | Catherine Arnst | 11/30/12 | Boston |
| Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing | Catherine Arnst | 11/29/12 | Boston |
| Rib-X Pharmaceuticals Lands Series B Financing Round | VentureDeal | 11/29/12 | Boston |
| Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers | Erin Kutz | 04/27/12 | Boston |
| Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News | Erin Kutz | 11/30/11 | Boston |
| Rib-X Pharma Files for IPO | Arlene Weintraub | 11/28/11 | Boston |
| Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News | Erin Kutz | 07/08/11 | Boston |
| Rib-X Inks Research Agreement With Sanofi | Erin Kutz | 07/06/11 | Boston |
| Rib-X Pharmaceuticals Garners $5,500,000 New Round | VentureDeal | 01/28/11 | Boston |
| Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News | Erin Kutz | 01/14/11 | Boston |
| Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics | Luke Timmerman | 01/11/11 | Boston |
| Rib-X Pharmaceuticals Receives $20,000,000 New Financing Round | VentureDeal | 01/11/11 | Boston |
| Rib-X Adds $5.5M Debt | Luke Timmerman | 06/11/10 | Boston |
| Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company | Luke Timmerman | 03/23/10 | Boston |
| Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy | Luke Timmerman | 02/16/10 | Boston |
| Rib-X Founder Gets Nobel Prize | Ryan McBride | 10/07/09 | Boston |
| Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner | Luke Timmerman | 08/05/09 | Boston |
| Rib-X Pharmaceuticals Inc. Lands $25,000,000 Series D Round | VentureDeal | 02/04/09 | Boston |
| Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial | Ryan McBride | 01/26/09 | Boston |
| Rib-X Pharmaceuticals Inc. Garners $25,000,000 New Funding | VentureDeal | 01/26/09 | Boston |
| Rib-X Reveals “Positive” Antibiotic Data | Ryan McBride | 12/08/08 | Boston |
| Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time | Ryan McBride | 10/02/08 | Boston |
| East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More | Ben Fidler | 02/14/14 | Boston |
| Athenahealth, iRobot, PerkinElmer, & More in Boston Life Sciences News | Erin Kutz | 09/14/12 | Boston |
| Gladstone, Sage Bionetworks Top ‘Best Places to Work’ List | Luke Timmerman | 08/01/12 | National |
| Boston Life Sciences News From Vertex, Eleven, RXi, & More | Erin Kutz | 05/11/12 | Boston |
| Antibiotic R&D is in Trouble: Here’s One Way to Fix It | Luke Timmerman | 05/07/12 | National |
| Biotech IPOs Start to Show Some Modest Signs of Life | Luke Timmerman | 04/30/12 | National |
| Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines | Erin Kutz | 12/02/11 | Boston |
| Venture Investment in New England Companies Is Down from a Year Ago; Here Are the Top 10 Deals from the First Quarter | Gregory T. Huang | 04/15/11 | Boston |
